The DisInformation Chronicle β’ 2005 implied HN points β’ 09 Jan 24
- FDA Commissioner is promoting products off-label, which is illegal marketing scheme criticized by Democrats
- There are concerns about conflicts of interest in reporting on COVID vaccine efficacy
- Clinicians may not always see conflicts of interest when receiving payments from pharmaceutical companies